Method of timing pulsatile flow of normothermic perfusate to the heart

Patent Citations (117)

Non-Patent Literature (107)

• http://dictionary.reference.com/browse/synchrony, Random House Unabridged Dictionary, 2006, accessed Dec. 23, 2008.Examiner
• Ahmad et al., “A Pathophysiologic Study of the Kidney Tubule to Optimize Organ Preservation Solutions,” Kidney Int. 66(1):77-90 (2004).Applicant
• Ananthaswamy “Machine Keeps Organs Alive for Longer,” New Scientist.com (2001).Applicant
• Bando et al. Oxygenated Perfluorocarbon, Recombinant Human Superoxide Dismutase, And Catalase Ameliorate Free Radical Induced Myocardial Injucy During Heart Preservation And Transplantation. J Thorac Cardiovasc Surg. 96:930-8(Dec. 1988).Applicant
• Benichou et al. Canine And Human Liver Preservation For 6 to 18 Hr by Cold Infusion. Transplantation. 24(6):407-411(Dec. 1977).Applicant
• Birkett et al., “The fatty-acid content and drug binding characteristics of commercial albumin preparations” Clin. Chem. Acta, 85:253-258 (1978).Applicant
• Blanchard et al. Techniques For Perfusion And Storage Of Heterotopic Heart Transplants In Mice. Microsurgery. 6:169-174(1985).Applicant
• Boggi et al., “Pancreas preservation with University of Wisconsin and Celsior solutions,” Transplant Proc. 36(3):563-5 (2004).Applicant
• Boggi et al., “Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study;” Transplantation 27:77(8):1186-90 (2004).Applicant
• Burt et al., “Myocardial Function After Preservation for 24 Hours,” Jour. Thorac. and Cardiovascular Surg. 92(2):238-46 (1986).Applicant
• Brasile et al., “Organ Preservation Without Extreme Hypothermia Using an Oxygen Supplemented Perfusate,” Art. Cells. Blood Subs. And Immob. Biotech. 22(4):1463-68 (1994).Applicant
• Canelo R, et al.; “Experience with Hystidine Tryptophan Ketoglutarate Versus University Wisconsin Preservation Solutions in Transplantation,” Int Surg. 88(3):145-51 (2003).Applicant
• Chambers et al., “Long-Term Preservation of the Heart: The Effect of Infusion Pressure During Continuous Hypothermic Cardioplegia,” Jour. of Heart and Lung Transp. 11(4):665-75 (1992).Applicant
• Chen et al., “Development of New Organ Preservation Solutions in Kyoto University,” Yonsei Medical Journal 46(6):1107-40 (2004).Applicant
• Chien et al., “A Simple Technique for Multiorgan Preservation,” Jour. of Thor. and Card. Surg. 95(1):55-61 (1988).Applicant
• Chien et al., “Functional Studies of the Heart During a 24-Hour Preservation Using a New Autoperfusion Preparation,” The Journal of Heart and Lung Transplantation 10(3):401-8 (1991).Applicant
• Christophi et al. “A Comparison Of Standard And Rapid Infusion Methods Of Liver Preservation During Multi-Organ Procurement,” Aust. N. Z. J. Surg. 61(9):692-94 (1991).Applicant
• Collins, BH “Organ Transplantation: What Is The State of The Art?,” Ann Surg. 238(6 Suppl):S72-89 (2003).Applicant
• Daemen et al., “Short-Term Outcome Of Kidney Transplants From Non-Heart-Beating Donors After Preservation By Machine Perfusion,” Transpl Int. 9(Suppl 1):S76-S80 (1996).Applicant
• Den Butter et al.; “Comparison of Solutions for Preservation of the Rabbit Liver as Tested by Isolated Perfusion,” Transpl. Int. 8(6):466-71 (1995).Applicant
• Denham et al., “Twenty-Four Hour Canine Renal Preservation by Pulsatile Perfusion, Hypothermic Storage, And Combinations Of The Two Methods,” Transplant Proc. 9(3):1553-56 (1977).Applicant
• Dobrian et al, “In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins,” Biochimica et Biophysica Acta (BBA) 1169:12-24 (1993).Applicant
• Eiseman et al., “A Disposable Liver Perfusion Chamber,” Surgery 6:1163-66 (1966).Applicant
• Faggian et al., “Donor Organ Preservation in High-Risk Cardiac Transplantation,” Transplant Proc. 36:617-19 (2004).Applicant
• Fehrenberg et al., “Protective Effects of B2 Preservation Solution in Comparison to a Standard Solution (Histidine-Tryptophan-Ketoglutarate/Bretschneider) in a Model of Isolated Autologous Hemoperfused Porcine Kidney,” Nephron Physiol. 96:52-58 (2004).Applicant
• Fourcade et al., “A New Method of Kidney Preservation with Collins' Solution,” Biomed. 21(7):308-11 (1974).Applicant
• Fraser et al., “Evaluation of Current Organ Preservation Methods for Heart-Lung Transplantation,” Transplant. Proc. 20(1 Suppl 1):987-90 (1988).Applicant
• Guarrera et al., “Pulsatile Machine Perfusion with Vasosol Solution Improves Early Graft Function After Cadaveric Renal Transplantation,” Transplantation 77(8):1264-68 (2004).Applicant
• Hachida et al. Abstract “Efficacy of Myocardial Preservation using HTK Solution in Continuous 120 Min Cross-Clamping Method—a Comparative Study with GIK Method,” Nippon Kyobu Geka Gakkai Zasshi 41(9):1495-1501 (1993).Applicant
• Hassanein et al., “Continuous Perfusion of Donor Hearts In The Beating State Extends Preservation Time And Improves Recovery Of Function,” The Journal of Thoracic and Cardiovascular Surgery 821-30 (1998).Applicant
• Heil et al., “A Controlled Comparison of Kidney Preservation by Two Methods: Machine Perfusion and Cold Storage,” Transplant. Proc. 19(1):2046 (1987).Applicant
• Imber et al.; “Advantages of Normothermic Perfusion Over Cold Storage in Liver Preservation,” Transplantation 73(5):701-09 (2002).Applicant
• Janssen et al., “UW is Superior to Celsior and HTK in the Protection of Human Liver Endothelial Cells Against Preservation Injury,” Liver Transpl. 10(12):1514-23 (2004).Applicant
• Kawamura et al., “Long-Term Preservation of Canine Pancreas by a New Simple Cold Storage Method Using Perfluorochemical—The Two-Layer Cold Storage Method (Euro-Collins' Solution/Perfluorochemical),” Kobe J med Sci. 38(2):135-45 (1992).Applicant
• Kelly “Current Strategies in Lung Preservation,” J. Lab Clin. Med. 136:427-40 (2000).Applicant
• Keshavjee et al., “A Method for Safe Twelve-Hour Pulmonary Preservation,” J. Thorac Cardiovasc Surg. 98:529-34 (1989).Applicant
• Kioka et al., “Twenty-Four-Hour Isolated Heart Preservation By Perfusion method With Oxygenated Solution Containing Perfluorochemicals And Albumin,” J. Heart Transplant. 5:437-43 (1986).Applicant
• Kozaki et al., “Usefulness Of A Combination Of Machine Perfusion And Pentoxifylline For Porcine Liver Transplantation From Non-Heart-Beating Donors With Prolonged Hypotension,” Transplant Proc. 29:3476-77 (1997).Applicant
• Kuroda et al., “A New, Simple Method for Cold Storage of the Pancreas Using Perfluorochemical,” Transplantation 46(3):457-60 (1988).Applicant
• Li et al., “Insulin in University of Wisconsin Solution Exacerbates the Ischemic Injury and Decreases the Graft Survival Rate in Rat Liver Transplantation,” Transplantation. 15:76(1):44-49 (2003).Applicant
• Li et al., “Insulin in UW Solution Exacerbates Hepatic Ischemia/Reperfusion Injury by Energy Depletion Through the IRS-2/SREBP-1C Pathway,” Liver Transpl. 10(9):1173-82 (2004).Applicant
• Liu et al., “Annexin V Assay-proven Anti-apoptotic Effect of Ascorbic Acid 2-glucoside after Cold Ischemia/Reperfusion Injury in Rat Liver Transplantation,” Acta Med. Okayama 57(5):209-16 (2003).Applicant
• Moisiuk et al., “Histidine-Tryptophan-Ketoglutarate Versus Euro-Collins For Preservation of Kidneys From Non-Heart-Beating Donors,” Transplant Proc. 28(1):202 (19996).Applicant
• Moller-Pedersen et al.; “Evaluation of Potential Organ Culture Media for Eye Banking Using Human Donor Corneas,” Br J Ophthamol. 85(9):1075-79 (2001).Applicant
• Morimoto et al., A Simple Method For Extended Heart-Lung Preservation By Autoperfusion. Trans Am Soc Artif Intern Organs. 30:320-24 (1984).Applicant
• Nicholson et al.; “A Comparison of Renal Preservation by Cold Storage and Machine Perfusion Using a Porcine Autotransplant Model,” Transplantation 78(3):333-37 (2004).Applicant
• Opelz et al., “Advantage of Cold Storage Over Machine Perfusion For Preservation Of Cadaver Kidneys” Transplantation. 33(1):64-68 (1982).Applicant
• Opelz et al., “Comparative Analysis of Kidney Preservation Methods. Collaborative Transplant Study,” Transplant Proc. 28(1):87-90 (1996).Applicant
• Petrovsky et al., Justification And Application Of A New Method For Transorganic Oxygen Preservation Of The Kidneys. Vestn Akad Med Nauk SSSR. (2):69-82(1989).Applicant
• Ploeg et al. Successful 72-Hour Cold Storage Of Dog Kidneys With UW Solution. Transplantation 46(2):191-96 (1988).Applicant
• Pokorny et al., “Histidine-Tryptophan-Ketoglutarate Solution for Organ Preservation in Human Liver Transplantation-a Prospective Multi-Centre Observation Study,” Transpl Int. 17(5):256-60 (2004).Applicant
• Potdar et al.; “Initial Experience Using Histidine-Tryptophan-Ketoglutarate Solution in Clinical Pancreas Transplantation,” Clin. Transplant. 18(6):661-65 (2004).Applicant
• Pozniak “Keeping Hearts Alive; Doctors Develop a High-Tech System to Salvage Donated Organs,” ABC News.com (2001).Applicant
• Reddy et al., “Preservation of Porcine Non-Heart Beating Donor Livers by Sequential Cold Storage and Warm Perfusion,” Transplantation 77(9):1328-32 (2004).Applicant
• Schon et al.; “Liver Transplantation After Organ Preservation with Normothermic Extracorporeal Perfusion,” Ann Surg. 233(1):114-23 (2001).Applicant
• Segel et al., “Recovery of Sheep Hearts After Perfusion Preservation or Static Storage With Crystalloid Media,” The Journal of Heart and Lung Transplantation 17:211-21 (1998).Applicant
• Shimokawa et al., “A New Lung Preservation Method of Topical Cooling by Ambient Cold Air Combined with High-Frequency Oscillation: An Experimental Study,” Transplant. Proc. 26(4):2364-66 (1994).Applicant
• Shimokawa et al., “A New Lung Preservation Method of Topical Cooling by Ambient Cold Air: an Experimental Study,” Transplant. Proc. 23 (1 Pt 1):653-54 (1991).Applicant
• Southard “The Right Solution for Organ Preservation” Business Briefings: Global Surgery, 79-84 (2004).Applicant
• Stubenitsky et al, “Kidney Preservation in the Next Millenium,” Transpl. Int. 12:83-91 (1999).Applicant
• Tang et al., “Warm Ischemia Lung Protection with Pinacidil: an ATP Regulated Potassium Channel Opener,” Ann Thorac Surg. 76:385-9 (2003).Applicant
• Turpin et al., “Perifusion of Isolated Rat Adipose Cells,” The Journal of Clinical Investigation, 60:442-448 (1977).Applicant
• “ViaSpan (Belzer UW) Cold Storage Solution,” Barr Laboratiories, Inc. (2002).Applicant
• Watanabe et al., “Effects of free fatty acids on the binding of bovine and human serum albumin with steroid hormones” Biochimica et Biophysica Acta (BBA), 1289:385-96 (1996).Applicant
• Zhengquang et al., “A Study on the Preservation of Rat Kidney with HX-III Solution,” WCUMS 31(3):347-49 (2000).Applicant
• Wicomb et al., “Cardiac Transplantation Following Storage of the Donor Heart by a Portable Hypothermic Perfusion System,” The Annals of Thoracic Surgery 37(3):243-48 (1984).Applicant
• Wicomb et al., “Orthotopic Transplantation of the Baboon Heart After 20 to 24 Hours Preservation By Continuous Hypothermic Perfusion With an Oxygenated Hyperosmolar Solution,” The Journal of Thoracic and Cardiovascular Surgery 83(1):133-40 (1982).Applicant
• Yland et al., “New Pulsatile Perfusion Method for Non-Heart-Beating Cadaveric Donor Organs: A Preliminary Report,” Transplantation Proceedings 25(6):3087-90 (1993).Applicant
• Zhang et al., “Research Progress on Preservation of Severed Limbs,” Chinese Journal of Reparative and Reconstructive Surgery 14(3):189-192 (2000).Applicant
• Chien et al. Canine Lung Transplantation After More Than Twenty-four Hours of Normothermic Preservation. J. Heart Lung Transplant. 16:3340-51 (1997).Applicant
• Menasche et al. Improved Recovery of Heart Transplants With A Specific Kit of Preservation Solutions. J. Thorac. Cardiovasc. Surg. 105(2):353-63 (1993).Applicant
• Vinten-Johansen et al. Reduction in Surgical Ischemic-Reperfusion Injury With Adenosine and Nitric Oxide Therapy. Ann. Thorac. Surg. 60(3):852-57 (1995).Applicant
• Lasley et al. Protective Effects of Adenosine in the Reversibly Injured Heart. Ann. Thorac. Surg. 60(3):843-46 (1995).Applicant
• Calhoon et al. Twelve-Hour Canine Heart Preservation With a Simple, Portable Hypothermic Organ Perfusion Device. Ann. Thorac. Surg. 62:91-3 (1996).Applicant
• Rao et al. Donor Blood Perfusion Improves Myocardial Recovery After Heart Transplantation. J. Heart Lung Transplant. 16(6):667-73 (1997).Applicant
• Pearl et al. Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution. J. Thorac. Cardiovasc. Surg. 107(7):257-64 (1994).Applicant
• Lefer, A.M. Attenuation of Myocardial Ischemia-Reperfusion Injury With Nitric Oxide Replacement Therapy. Ann. Thorac. Surg. 60(3):847-51 (1995).Applicant
• Hartman, J. C. The Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of ACE Inhibitors. Ann. Thor. Surg. 60:789-92 (1995).Applicant
• Rinder et al. Blockade of C5a and C5b-9 Generation Inhibits Leukocyte and Platelet Activation during Extracorporeal Circulation. J. Clin. Invest. 96:3(1564-72). 1995.Applicant
• Aoki, M. et al. Anti-CD18 Attenuates Deleterious Effects of Cardiopulmonary Bypass and Hypothermic Circulatory Arrest in Piglets. J. Card. Surg. 10:407-17 (1995).Applicant
• Rosenkranz, E.R. Substrate Enhancement of Cardioplegic Solution: Experimental Studies and Clinical Evaluation. Ann. Thorac. Surg. 60:797-800 (1995).Applicant
• Engelman et al. Influence of Steroids on Complement and Cytokine Generation After Cardiopulmonary Bypass. Ann. Thorac. Surg. 60(3):801-04 (1995).Applicant
• Boyle, Jr. et al. Ischemia-Reperfusion Injury. Ann. Thorac. Surg. 64:524-30 (1997).Applicant
• Li, G. et al. Functional Recovery in Rabbit Heart after Preservation with a Blood Cardioplegic Solution and Perfusion. J. Herat Lung Transplant. 12(2)263-70 (1993).Applicant
• Seccombe et al. Coronary Artery Endothelial Function After Myocardial Ischemia and Reperfusion. Ann. Thorac. Surg. 60(3):778-88 (1995).Applicant
• Mankad et al. Endothelial dysfunction caused by University of Wisconsin preservation solution in the rat heart. J. Thorac. Cardiovasc. Surg. 104(6):1618-24 (1992).Applicant
• Sunamori et al. Relative Advantages of Nondepolarizing Solution to Depolarizing University of Wisconsin Solution in Donor Heart Preservation. Transplant. Proc. 25(1):1613-17 (1993).Applicant
• Pinsky et al. Restoration of the cAMP Second Messenger Pathway Enhances Cardiac Preservation for Transplantation in a Heterotopic Rat Model. J. Clin. Invest. 92(6):2944-3002 (1993).Applicant
• Richens et al. Clinical Study of Crystalloid Cardioplegia vs Aspartate-Enriched Cardioplegia Plus Warm Reperfusion for Donor Heart Preservation. Transplant. Proc. 24(1):1608-10 (1993).Applicant
• Finn et al. Effects of Inhibition of Complement Activation Using Recombinant Soluble Complement Receptor 1 on Neutrophil CD11B/CD18 and L-Selectin Expression and Release of Interleukin-8 and Elastase in Simulated Cardiopulmonary Bypass. J. Thorac. Cardiovasc. Surg. 111(2):451-49 (1996).Applicant
• Wicomb et al. 24-Hour Rabbit Heart Storage with UW Solution. Transplantation. 48(1):6-9 (1989).Applicant
• Menasche et al. Experimental evaluation of Celsior®, a new heart preservation solution. Eur. J. Cardiothor. Surg. 8:207-13 (1994).Applicant
• Ferrera et al. Comparison of Different Techniques of Hypothermic Pig Heart Preservation. Ann. Thorac. Surg. 57(5):1233-39 (1994).Applicant
• Gundry et al. Successful Transplantation of Hearts Harvested 30 Minutes After Death From Exsanguination. Ann. Thorac. Surg. 53(5):772-75 (1992).Applicant
• Demertzis et al. University of Wisconsin Versus St. Thomas' Hospital Solution for Human Donor Heart Preservation. Ann. Thorac. Surg. 55:1131-7 (1993).Applicant
• Schwalb et al. New Solution for Prolonged Myocardial Preservation for Transplantation. J. Heart Lung Transplant. 17(2):222-29 (1998).Applicant
• Drexler et al. Effect of L-Arginine on Coronary Endothelial Function in Cardiac Transplant Recipients. Circulation.89(4):1615-23 (1994).Applicant
• Sato, H. et al. Supplemental L-Arginine During Cardioplegic Arrest and Reperfusion Avoids Regional Postischemic Injury. J. Thorac. Cardiovasc. Surg. 110(2):302-14 (1995).Applicant
• Matsuno et al. The Effect of Machine Perfusion Preservation Versus Cold Storage on the Function of Kidneys from Non-Heart-Beating Donors. Transplantation. 57(2):293-94 (1994).Applicant
• Tesi et al. Pulsatile Kidney Perfusion for Preservation and Evaluation: Use of High-Risk Kidney Donors to Expand the Donor Pool. Transplant. Proc. 25(6):3099-100 (1993).Applicant
• Shirakura et al. Multiorgan Procurement from Non-Heart-Beating Donors by use of Osaka University Cocktail, Osaka Rinse Solution, and the Portable Cardiopulmonary Bypass Machine. Transplant. Proc. 25(6):3093-94 (1993).Applicant
• Matsuno et al. Effectiveness of Machine Perfusion Preservation as a Viability Determination Method for Kidneys Procured from Non-Heart-Beating Donors. Transplant. Proc. 26(4):2421-22 (1994).Applicant
• Habazettl et al. Improvement in Functional Recovery of the Isolated Guinea Pig Heart After Hyperkalemic Reperfusion with Adenosine. J. Thorac. Cardiovasc. Surg. 111(1):74-84 (1996).Applicant
• Menasche, P. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr. Opin. Cardiology. 10:597-604 (1995).Applicant
• Segel et al. Posttransplantation Function of Hearts Preserved with Fluorochemical Emulsion. J. Heart Lung Transplant. 13(4):669-80 (1994).Applicant
• Birkett et al. The Fatty Acid Content and Drug Binding Characteristics of Commercial Albumin Preparations. Clin. Chem. Acta. 85:253-58 (1978).Applicant
• The Merck Index, 11th ed. Entry 4353 (pp. 699-700) (1989).Applicant